Top

Published in:

01-07-2014 | Original Paper

The Ethical, Legal and Human Rights Concerns Raised by Licensing HIV Self-Testing for Private Use

Authors: Lucy Allais, Francois Venter

Published in: AIDS and Behavior | Special Issue 4/2014

Abstract

We argue that there are no compelling ethical grounds for not allowing the sale of HIV self-tests to the public, so long as reasonably robust protections are in place to protect against coerced testing, and so long as the ease of use of the test is validated carefully in each country in which it is used, with attention to information about linkage to treatment, social and psychological support. The tests are not likely to be harmful in a way that justifies restricting people’s access to them, and have plausible benefits. Whether and how self-testing should be used in public health programs will depend on complex policy questions concerning priorities, efficacy and cost.

Alcorn A. Legal barrier to self-testing for HIV in UK to be lifted. NAM AIDSMAP [cited 2013 Oct 14]. Available from: http://www.aidsmap.com/Legal-barrier-to-self-testing-for-HIV-in-UK-to-be-lifted/page/2731557/.

World Health Organization (WHO). Report on the first international symposium on self-testing for HIV: the legal, ethical, gender, human rights and public health implications of HIV self testing scale up. Geneva: WHO; Apr 8–9, 2013 [cited 2013 Oct 14]. Available from: http://apps.who.int/iris/bitstream/10665/85267/1/9789241505628_eng.pdf.

Pant Pai N, Sharma J, Shivkumar S, Pillay S, Vadnais C, et al. Supervised and unsupervised self-testing for HIV in high- and low-risk populations: asystematic review. PLoS Med. 2013;10(4):e1001414. doi:10.1371/journal.pmed.1001414.PubMedCentralPubMedCrossRef

Choko AT, MacPherson P, Webb EL, Ball H, Sambakunsi R, Mdolo A, Makombe SD, Desmond N, Hayes R, and Corbett EL. One year outcomes following community-based HIV self-testing: a prospective study in Malawi, Abstract 147. Presented at Conference on Retroviruses and Opportunistic Infections, Boston. 3–6 Mar 2014.

Asiimwe S1, Oloya J, Song X, Whalen CC. Accuracy of un-supervised versus provider-supervised self-administered HIV testing in Uganda: a randomized implementation trial. AIDS Behav. Apr 2014 [cited 2014 May 27]. Available from: http://www.ncbi.nlm.nih.gov/pubmed/24691923.

United States Food and Drug Administration (US FDA). OraQuick^®In-home HIV Test summary of safety and effectiveness. Silver Spring, MD: US FDA; 2012 [cited 2014 May 4]. Available from: http://www.fda.gov/downloads/BiologicsBloodVaccines/BloodBloodProducts/ApprovedProducts/PremarketApprovalsPMAs/UCM312534.pdf.

Krause J, Subklew-Sehume F, Kenyon C, Colebunders R. Acceptability of HIV self-testing: a systematic literature review. BMC Public Health. 2013;8(13):735. doi:10.1186/1471-2458-13-735.CrossRef

World Health Organization (WHO). Guidance on provider-initiated HIV testing and counselling in health facilities. Geneva: WHO; 2007 [cited 2014 Jan 4]. Available from: http://whqlibdoc.who.int/publications/2007/9789241595568_eng.pdf

South African National Department of Health. National HIV counselling and testing policy guidelines, Pretoria: National Department of Health; 2010 [cited 2014 May 21]. Available from: http://www.uj.ac.za/EN/CorporateServices/ioha/Documentation/Documents/hct_policy_guidelines%202010.pdf

10.

The World Bank. Data South Africa. World Bank Group; 2014 [cited 2014 Jan 5]. Available from: http://data.worldbank.org/country/south-africa

11.

The Joint United Nations Programme on HIV/AIDS (UNAIDS). UNAIDS report on the global AIDS epidemic. Geneva: UNAIDS; 2013: p.80 [cited 2014 Jan 4]. Available from: http://www.unaids.org/en/media/unaids/contentassets/documents/epidemiology/2013/gr2013/UNAIDS_Global_Report_2013_en.pdf

12.

Ngʼangʼa A, Waruiru W, Ngare C, Ssempijja V, Gachuki T, Njoroge I, Oluoch P, Kimanga DO, Maina WK, Mpazanje R, Kim AA, KAIS Study Group. The status of HIV testing and counseling in Kenya: results from a nationally representative population-based survey. J Acquir Immune Defic Syndr. 2014;66(Suppl 1):S27–36. doi:10.1097/QAI.0000000000000102.PubMedCrossRef

13.

Venkatesh KK, Madiba P, De Bruyn G, Lurie MN, Coates TJ, Gray GE. Who gets tested for HIV in a South African urban township? Implications for test and treat and gender-based prevention interventions. J Acquir Immune Defic Syndr. 2011;56(2):151–65. doi:10.1097/QAI.0b013e318202c82c.PubMedCentralPubMedCrossRef

14.

Fonner VA, Denison J, Kennedy CE, O’Reilly K, Sweat M. Voluntary counseling and testing (VCT) for changing HIV-related risk behavior in developing countries. Cochrane Database Syst Rev. 2012;9:CD001224. doi:10.1002/14651858.CD001224.pub4.PubMedCentralPubMed

15.

Rosen S, Fox MP. Retention in HIV care between testing and treatment in sub-Saharan Africa: a systematic review. PLoS Med. 2011;8(7):e1001056. doi:10.1371/journal.pmed.1001056.PubMedCentralPubMedCrossRef

16.

Richter M, Venter WD, Gray A. Home self-testing for HIV: AIDS exceptionalism gone wrong. S Afr Med J. 2010;100(10):636–42.PubMed

17.

Weait M. Intimacy and responsibility: the criminalization of HIV transmission. Oxon: Routledge-Cavendish; 2007.

18.

Jürgens R, Cohen J, Cameron E, Burris S, Clayton M, Elliott R, et al. 10 Reasons to oppose the criminalization of HIV exposure or transmission; New York: Open Society Institute; 2008 [cited 2013 Oct 19]. Available from: http://www.opensocietyfoundations.org/sites/default/files/10reasons_20081201.pdf.

Title: The Ethical, Legal and Human Rights Concerns Raised by Licensing HIV Self-Testing for Private Use
Authors: Lucy Allais
Francois Venter
Publication date: 01-07-2014
Publisher: Springer US
Published in: AIDS and Behavior / Issue Special Issue 4/2014
Print ISSN: 1090-7165
Electronic ISSN: 1573-3254
DOI: https://doi.org/10.1007/s10461-014-0823-y

ACC 2024 Congress Coverage

Heart Failure Video

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

The Ethical, Legal and Human Rights Concerns Raised by Licensing HIV Self-Testing for Private Use

Abstract

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Special Issue 4/2014

Modelling the Potential Population Impact and Cost-Effectiveness of Self-Testing for HIV: Evaluation of Data Requirements

Factors Associated with Acceptability of HIV Self-Testing Among Health Care Workers in Kenya

Realizing the Potential for HIV Self-Testing

A Review of the Evidence of Harm from Self-Tests

Factors Shaping Initial Decision-Making to Self-test Amongst Cohabiting Couples in Urban Blantyre, Malawi

What Should the Ideal HIV Self-Test Look Like? A Usability Study of Test Prototypes in Unsupervised HIV Self-Testing in Kenya, Malawi, and South Africa

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page